A61K 39/001191
Melan-a/mart
Official title: {Melan-A/MART}
A61K39/001191 (Melan-a/mart) appears on 118 US grants and 265 published applications in this corpus.
Search patents in A61K- Granted patents
- 118
- Published applications
- 265
- Assignees
- 134
- Inventors
- 428
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 3 | 9 |
| 2003 | 1 | 5 |
| 2004 | 0 | 11 |
| 2005 | 2 | 6 |
| 2006 | 0 | 8 |
| 2007 | 3 | 4 |
| 2008 | 1 | 9 |
| 2009 | 2 | 2 |
| 2010 | 4 | 4 |
| 2011 | 6 | 13 |
| 2012 | 2 | 15 |
| 2013 | 0 | 5 |
| 2014 | 5 | 11 |
| 2015 | 3 | 18 |
| 2016 | 8 | 28 |
| 2017 | 5 | 13 |
| 2018 | 10 | 16 |
| 2019 | 7 | 9 |
| 2020 | 6 | 17 |
| 2021 | 14 | 18 |
| 2022 | 9 | 12 |
| 2023 | 8 | 12 |
| 2024 | 8 | 6 |
| 2025 | 3 | 10 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Metabolically stabilized double stranded mRNA26 May 2026US 12,636,304 B2University of Iowa Research Foundation
- T cell receptors and methods of use thereof17 Mar 2026US 12,577,287 B2University Health Network
- Polymeric nanovaccines and uses thereof3 Mar 2026US 12,564,643 B2Ramot at Tel-Aviv University Ltd.
- Cancer vaccine19 Aug 2025US 12,390,514 B2President and Fellows of Harvard College
- Compositions and methods for delivery of biomacromolecule agents10 Jun 2025US 12,324,843 B2The Regents of the University of Michigan
- Polymeric nanovaccines and uses thereof21 May 2026US 2026/0137804 A1Ramot at Tel-Aviv University Ltd.
- Systems, formulations and methods for generating universal peptide/mhc complexes with engineered disulfide connecting the heavy and light chains9 Apr 2026US 2026/0097105 A1
- Uveal melanoma vaccine26 Feb 2026US 2026/0053905 A1University of Virginia Patent Foundation
- Formulations for neoplasia vaccines9 Oct 2025US 2025/0312458 A1The Broad Institute, Inc.
- New vaccinal strategy2 Oct 2025US 2025/0302976 A1Inserm (Institut National De La Sante Et De La Recherche Medicale)
Most cited
By later US patents
- DNA vaccine and methods for its use107US 6,472,375 B1John Wayne Cancer Institute · 2002
- Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same90US 5,891,432 AThe Immune Response Corporation · 1999
- Composition comprising a complexed (M)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof79US 9,572,874 B2CureVac AG · 2017
- Pharmaceutical composition containing a stabilised mRNA optimised for translation in its coding regions75US 10,188,748 B2CureVac AG · 2019
- Dock-and-lock (DNL) vaccines for cancer therapy68US 7,901,680 B2IBC Pharmaceuticals, Inc. · 2011